Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Proteomic Analysis Shows Constitutive Secretion of MIF and p53-associated Activity of COX-2-/- Lung Fibroblasts.

Dave M, Islam ABMMK, Jensen RV, Rostagno A, Ghiso J, Amin AR.

Genomics Proteomics Bioinformatics. 2017 Dec;15(6):339-351. doi: 10.1016/j.gpb.2017.03.005. Epub 2017 Dec 13.

2.

In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance.

Anisuzzaman AS, Haque A, Wang D, Rahman MA, Zhang C, Chen Z, Chen ZG, Shin DM, Amin AR.

Mol Cancer Ther. 2017 Apr;16(4):729-738. doi: 10.1158/1535-7163.MCT-16-0683. Epub 2017 Jan 23.

3.

Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.

Wang D, Peng S, Amin AR, Rahman MA, Nannapaneni S, Liu Y, Shin DM, Saba NF, Eichler JF, Chen ZG.

PLoS One. 2016 Dec 29;11(12):e0168450. doi: 10.1371/journal.pone.0168450. eCollection 2016.

4.

HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.

Wang D, Qian G, Zhang H, Magliocca KR, Nannapaneni S, Amin AR, Rossi M, Patel M, El-Deiry M, Wadsworth JT, Chen Z, Khuri FR, Shin DM, Saba NF, Chen ZG.

Clin Cancer Res. 2017 Feb 1;23(3):677-686. doi: 10.1158/1078-0432.CCR-16-0558. Epub 2016 Jun 29.

5.

Genomic, Lipidomic and Metabolomic Analysis of Cyclooxygenase-null Cells: Eicosanoid Storm, Cross Talk, and Compensation by COX-1.

Islam AB, Dave M, Amin S, Jensen RV, Amin AR.

Genomics Proteomics Bioinformatics. 2016 Apr;14(2):81-93. doi: 10.1016/j.gpb.2014.09.005. Epub 2016 Mar 21.

6.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

7.

Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.

Anisuzzaman AS, Haque A, Rahman MA, Wang D, Fuchs JR, Hurwitz S, Liu Y, Sica G, Khuri FR, Chen ZG, Shin DM, Amin AR.

Cancer Prev Res (Phila). 2016 Jan;9(1):63-73. doi: 10.1158/1940-6207.CAPR-15-0240. Epub 2015 Oct 28.

8.

FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Haque A, Rahman MA, Fuchs JR, Chen ZG, Khuri FR, Shin DM, Amin AR.

Cancer Lett. 2015 Jul 28;363(2):166-75. doi: 10.1016/j.canlet.2015.04.017. Epub 2015 Apr 24.

9.

Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways.

Amin AR, Haque A, Rahman MA, Chen ZG, Khuri FR, Shin DM.

PLoS One. 2015 Apr 24;10(4):e0124218. doi: 10.1371/journal.pone.0124218. eCollection 2015.

10.

Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Amin ARMR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM.

Semin Cancer Biol. 2015 Dec;35 Suppl:S55-S77. doi: 10.1016/j.semcancer.2015.02.005. Epub 2015 Mar 6. Review.

11.
12.

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.

Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Ma J, Chen ZG, Saba NF.

Mol Cancer Ther. 2014 Jul;13(7):1826-36. doi: 10.1158/1535-7163.MCT-13-1093. Epub 2014 Apr 18.

13.

Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.

Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, Chen ZG, Arbiser JL, Shin DM.

PLoS One. 2014 Feb 25;9(2):e86369. doi: 10.1371/journal.pone.0086369. eCollection 2014.

14.

OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

Ng WL, Chen G, Wang M, Wang H, Story M, Shay JW, Zhang X, Wang J, Amin AR, Hu B, Cucinotta FA, Wang Y.

Cell Death Dis. 2014 Jan 23;5:e1024. doi: 10.1038/cddis.2013.563.

15.

Updating the Vibrio clades defined by multilocus sequence phylogeny: proposal of eight new clades, and the description of Vibrio tritonius sp. nov.

Sawabe T, Ogura Y, Matsumura Y, Feng G, Amin AR, Mino S, Nakagawa S, Sawabe T, Kumar R, Fukui Y, Satomi M, Matsushima R, Thompson FL, Gomez-Gil B, Christen R, Maruyama F, Kurokawa K, Hayashi T.

Front Microbiol. 2013 Dec 27;4:414. doi: 10.3389/fmicb.2013.00414. eCollection 2013. Erratum in: Front Microbiol. 2014;5:583.

16.

Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X, Amin AR, Chen Z, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2014 Jan;7(1):65-73. doi: 10.1158/1940-6207.CAPR-13-0230.

17.

RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.

Rahman MA, Amin AR, Wang D, Koenig L, Nannapaneni S, Chen Z, Wang Z, Sica G, Deng X, Chen ZG, Shin DM.

Clin Cancer Res. 2013 Jul 1;19(13):3416-28. doi: 10.1158/1078-0432.CCR-13-0073. Epub 2013 May 29.

18.

Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib.

Dave M, Amin AR.

Immunol Lett. 2013 Apr;152(1):47-54. doi: 10.1016/j.imlet.2013.04.002. Epub 2013 Apr 16.

PMID:
23603366
19.

New perspectives of curcumin in cancer prevention.

Park W, Amin AR, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2013 May;6(5):387-400. doi: 10.1158/1940-6207.CAPR-12-0410. Epub 2013 Mar 6. Review. Erratum in: Cancer Prev Res (Phila). 2017 Jun;10 (6):371.

20.

Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR, Müller S, Lewis M, Sica G, Kono S, Brandes JC, Grist WJ, Moreno-Williams R, Beitler JJ, Thomas SM, Chen Z, Shin HJ, Grandis JR, Khuri FR, Chen ZG.

Clin Cancer Res. 2013 Mar 1;19(5):1244-56. doi: 10.1158/1078-0432.CCR-12-3149. Epub 2013 Feb 19.

21.

The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Wang D, Müller S, Amin AR, Huang D, Su L, Hu Z, Rahman MA, Nannapaneni S, Koenig L, Chen Z, Tighiouart M, Shin DM, Chen ZG.

Clin Cancer Res. 2012 Sep 1;18(17):4589-99. doi: 10.1158/1078-0432.CCR-11-3127. Epub 2012 Jul 24.

22.

Cancer-related fatigue.

Johnson RL, Amin AR, Matzo M.

Am J Nurs. 2012 Apr;112(4):57-60. doi: 10.1097/01.NAJ.0000413462.26668.96. No abstract available.

PMID:
22456570
23.

Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.

Rahman MA, Amin AR, Wang X, Zuckerman JE, Choi CH, Zhou B, Wang D, Nannapaneni S, Koenig L, Chen Z, Chen ZG, Yen Y, Davis ME, Shin DM.

J Control Release. 2012 May 10;159(3):384-92. doi: 10.1016/j.jconrel.2012.01.045. Epub 2012 Feb 8.

24.

RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells.

Rao J, Elliott MR, Leitinger N, Jensen RV, Goldberg JB, Amin AR.

Cell Immunol. 2011;270(2):103-13. doi: 10.1016/j.cellimm.2011.05.012. Epub 2011 May 24.

25.

Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.

Rao J, DiGiandomenico A, Artamonov M, Leitinger N, Amin AR, Goldberg JB.

Cell Immunol. 2011;270(2):95-102. doi: 10.1016/j.cellimm.2011.04.011. Epub 2011 May 5.

26.

Chemopreventive potential of natural compounds in head and neck cancer.

Rahman MA, Amin AR, Shin DM.

Nutr Cancer. 2010;62(7):973-87. doi: 10.1080/01635581.2010.509538. Review.

27.

Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.

Amin AR, Wang D, Zhang H, Peng S, Shin HJ, Brandes JC, Tighiouart M, Khuri FR, Chen ZG, Shin DM.

J Biol Chem. 2010 Nov 5;285(45):34557-65. doi: 10.1074/jbc.M110.141135. Epub 2010 Sep 8.

28.

Chemoprevention of head and neck cancer with green tea polyphenols.

Kim JW, Amin AR, Shin DM.

Cancer Prev Res (Phila). 2010 Aug;3(8):900-9. doi: 10.1158/1940-6207.CAPR-09-0131. Epub 2010 Jul 27. Review.

29.

Restoration of p53 functions protects cells from concanavalin A-induced apoptosis.

Amin AR, Thakur VS, Gupta K, Jackson MW, Harada H, Agarwal MK, Shin DM, Wald DN, Agarwal ML.

Mol Cancer Ther. 2010 Feb;9(2):471-9. doi: 10.1158/1535-7163.MCT-09-0732. Epub 2010 Feb 2.

30.

Mediterranean diets: are they practical in the Western world?

Amin AR, Bailey JL.

Kidney Int. 2009 Dec;76(11):1127-9. doi: 10.1038/ki.2009.378.

31.

Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.

Amin AR, Khuri FR, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2009 Jun;2(6):538-45. doi: 10.1158/1940-6207.CAPR-09-0063. Epub 2009 May 26.

32.

Perspectives for cancer prevention with natural compounds.

Amin AR, Kucuk O, Khuri FR, Shin DM.

J Clin Oncol. 2009 Jun 1;27(16):2712-25. doi: 10.1200/JCO.2008.20.6235. Epub 2009 May 4. Review.

33.

DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation.

Hastak K, Paul RK, Agarwal MK, Thakur VS, Amin AR, Agrawal S, Sramkoski RM, Jacobberger JW, Jackson MW, Stark GR, Agarwal ML.

Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6314-9. doi: 10.1073/pnas.0802080105. Epub 2008 Apr 23.

34.

Coordinated upregulation of a series of endogenous antioxidants and phase 2 enzymes as a novel strategy for protecting renal tubular cells from oxidative and electrophilic stress.

Zhu H, Zhang L, Amin AR, Li Y.

Exp Biol Med (Maywood). 2008 Jun;233(6):753-65. doi: 10.3181/0801-RM-5. Epub 2008 Apr 11.

PMID:
18408143
35.
36.

SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.

Amin AR, Thakur VS, Paul RK, Feng GS, Qu CK, Mukhtar H, Agarwal ML.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5419-24. Epub 2007 Mar 16.

37.

Functional genomics approaches in arthritis.

Attur MG, Dave MN, Amin AR.

Am J Pharmacogenomics. 2004;4(1):29-43. Review.

PMID:
14987120
38.

The PLC-PKC cascade is required for IL-1beta-dependent Erk and Akt activation: their role in proliferation.

Amin AR, Ichigotani Y, Oo ML, Biswas MH, Yuan H, Huang P, Mon NN, Hamaguchi M.

Int J Oncol. 2003 Dec;23(6):1727-31.

PMID:
14612947
39.
40.

Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase.

Oo ML, Senga T, Thant AA, Amin AR, Huang P, Mon NN, Hamaguchi M.

Oncogene. 2003 Mar 6;22(9):1411-7.

PMID:
12618767
41.

"A system biology" approach to bioinformatics and functional genomics in complex human diseases: arthritis.

Attur MG, Dave MN, Tsunoyama K, Akamatsu M, Kobori M, Miki J, Abramson SB, Katoh M, Amin AR.

Curr Issues Mol Biol. 2002 Oct;4(4):129-46.

42.
43.

Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine.

Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR.

Osteoarthritis Cartilage. 2002 Jan;10(1):1-4. No abstract available. Erratum in: Osteoarthritis Cartilage. 2003 Sep;11(9):706.

44.

Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.

Attur MG, Dave MN, Leung MY, Cipolletta C, Meseck M, Woo SL, Amin AR.

J Immunol. 2002 Feb 15;168(4):2001-10.

45.

The role of nitric oxide in tissue destruction.

Abramson SB, Amin AR, Clancy RM, Attur M.

Best Pract Res Clin Rheumatol. 2001 Dec;15(5):831-45. Review.

PMID:
11812024
46.

Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis.

Abramson SB, Attur M, Amin AR, Clancy R.

Curr Rheumatol Rep. 2001 Dec;3(6):535-41. Review.

PMID:
11709117
47.

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.

Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, Amin AR, Hamaguchi M.

Clin Exp Metastasis. 2000;18(5):423-8.

PMID:
11467775
48.

Osteopontin: an intrinsic inhibitor of inflammation in cartilage.

Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR.

Arthritis Rheum. 2001 Mar;44(3):578-84.

49.

The pleiotropic functions of aspirin: mechanisms of action.

Amin AR, Attur MG, Pillinger M, Abramson SB.

Cell Mol Life Sci. 1999 Oct 15;56(3-4):305-12. Review.

PMID:
11212358
50.

COX-2, NO, and cartilage damage and repair.

Amin AR, Dave M, Attur M, Abramson SB.

Curr Rheumatol Rep. 2000 Dec;2(6):447-53. Review.

PMID:
11123096

Supplemental Content

Support Center